HOXA5 was upregulated in CL and ME subtypes by comparing with NE and PN subtypes in pan-glioma analysis in TCGA data set, where CL subtype had the highest expression of HOXA5 (P <0.001; Figure 2A). Here, HOXA5 is linked to central nervous system cancer.